Chaim Lebovits - May 10, 2024 Form 4/A Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
President & CEO
Signature
/s/ Chaim Lebovits
Stock symbol
BCLI
Transactions as of
May 10, 2024
Transactions value $
$18,865
Form type
4/A
Date filed
7/31/2024, 04:07 PM
Date Of Original Report
May 14, 2024
Previous filing
May 7, 2024
Next filing
May 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Purchase $9.3K +20K +1.89% $0.47 1.08M May 10, 2024 Direct F1
transaction BCLI Common Stock Purchase $4.67K +10K +0.93% $0.47 1.09M May 11, 2024 Direct F1
transaction BCLI Common Stock Purchase $4.9K +10K +0.92% $0.49 1.1M May 13, 2024 Direct F1
holding BCLI Common Stock 2M May 10, 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 14, 2024, the Reporting Person filed a Form 4 which inadvertently included incorrect transaction codes due to an administrative error. This amendment is being filed solely to reflect the correct transaction code 'P' instead of transaction code 'A'.
F2 Includes (i) 1,933,794 shares of Common Stock owned by ACCBT Corp. and (ii) 67,053 shares of Common Stock owned by ACC International Holdings Ltd. Reporting Person may be deemed the beneficial owner of these shares.